THE RELATIONSHIP BETWEEN LEUKOCYTE COUNT WITH TUBERCULOSIS (TB) LESION AREA IN CHEST X-RAY EXAMINATION

Main Article Content

Nasywa Talitha Zahran
Program Studi Pendidikan Dokter, Fakultas Kedokteran Universitas Brawijaya, Indonesia
Yuyun Yueniwati
Departemen Radiologi, Fakultas Kedokteran Universitas Brawijaya, Indonesia
Alfred Julius Petrarizky
Departemen Radiologi, Fakultas Kedokteran Universitas Brawijaya, Indonesia

Leukocyte count is one of the hematological parameters known to help diagnose organ damage and serve as an indicator of the body's immune system. Leukocyte counts are associated with the extent of lesions in the lung fields of tuberculosis patients on Chest X-ray (CXR) examination. This study aims to evaluate whether the leukocyte count can be used as an alternative indicator for early detection and severity assessment of tuberculosis without relying on CXR results. Therefore, this study was conducted with the aim to determine the relationship between leukocyte count and TB lesion area from Chest X-ray (CXR) examination. This study is a quantitative research type of observational analysis with a cross sectional study design conducted on 60 research subjects derived from medical record data of TB patients at Saiful Anwar Hospital, Malang, from January 2022 to December 2023. The data obtained were analyzed using the Chi-Square method, which showed that there was no significant relationship between leukocyte count and the extent of TB lesions from the CXR examination (Chi-Square, p=0.706). The conclusion of this study is that leukocyte count is not associated with the description of the lesion area of TB patients.

Keywords: Leukocyte TB lesion area, CXR Tuberculosis
1. Ainurohmah, S., Purwaeni, E., Dan Kafesa, A., 2020. Perbandingan Jumlah Leukosit Pada Penderita Tuberkulosis Sebelum dan Sesudah Pengobatan Obat Anti Tuberkulosis Fase Intensif. Jurnal Vol 10 No.2
2. Ak, S.B., Analis, J., Poltekkes, K., Makassar, K. 2018. Analisis Jumlah Leukosit dan Jenis Leukosit pada Individu yang Tidur dengan Lampu Menyala dan yang Dipadamkan. Jurnal Media Analis Kesehatan, 1(1).
3. Akhadi, M. 2020. Sinar-X Menjawab Masalah Kesehatan. Yogyakarta: Penerbit Deepublish
4. Akhigbe, R.O., Ugwu, A. C., Ogolodom, M. P., Ihua, N., Maduka, B. U., & Jayeoba, B. I. 2019. Evaluation of Chest Radiographic Patterns and Its Relationship with Hematological Parameters in Patients with Pulmonary Tuberculosis in Lagos Metropolis, Nigeria. Health Science Journal, 13(1), 628.
5. Andriani, E., Prameswari, G.N. 2018. Keterlambatan Berobat Pasien Tuberkulosis Paru di Puskesmas Pringapus. HIGEIA (Journal of Public Health Research and Development), 2(2), pp.272-283.
6. Bestari, G., 2015. Perbedaan Jumlah Leukosit Sebelum dan Sesudah Pemberian Obat Anti Tuberkulosis pada Fase Awal (Doctoral dissertation, Universitas Muhammadiyah Yogyakarta).
7. Hairani, T., 2019. Gambaran Jumlah Leukosit Pada Penderita Tuberkulosis Paru Sebelum dan Sesudah Dua Bulan Mengonsumsi Obat Anti Tuberkulosis di RS Khusus Paru Medan.
8. Inayah, S., Wahyono, B. 2019. Penanggulangan Tuberkulosis Paru dengan Strategi DOTS. HIGEIA (Journal of Public Health Research and Development), 3(2): 223-233.
9. Kahase, D., Solomon, A., Alemayehu, M. 2020. Evaluation of peripheral blood parameters of pulmonary tuberculosis patients at St. Paul’s Hospital Millennium Medical College, Addis Ababa, Ethiopia: comparative study. Journal of blood medicine, 11: 115-121.
10. Katherina. 2020. Karakteristik Lesi pada Foto Toraks Kasus Tuberkulosis Paru di RSUP Dr. Mohammad Hoesin Palembang.
11. Kementerian Kesehatan Republik Indonesia. 2022. Profil Kesehatan Indonesia 2022. Kementerian Kesehatan Republik Indonesia, Jakarta.
12. Khaironi, S., Rahmita, M., Siswani, R. 2017. Gambaran Jumlah Leukosit dan Jenis Leukosit Pada Pasien Tuberkulosis Paru Sebelum Pengobatan dengan Setelah Pengobatan Satu Bulan Intensif Di Puskesmas Pekanbaru. Jurnal Analis Kesehatan Klinikal Sains. 5(2).
13. Lewar, L.S. 2018. Perbedaan Jumlah Monosit dan Laju Endap Darah pada Penderita Tuberkulosis Paru Lesi Luas, Lesi Minimal dan Pasien Sehat di RSUD dr. Saiful Anwar Malang. Universitas Brawijaya.
14. Lubis, Fadel, M.N. 2021. Analisa Jenis dan Jumlah Sel Leukosit pada Penderita Tuberculosis yang Menjalani Pengobatan Obat Anti Tuberculosis Selama 2 Bulan di Rumah Sakit Khusus Paru Medan.
15. Mardina, V., Niagita, C.R. 2019. Pemeriksaan Jumlah Leukosit, Laju Endap Darah dan Bakteri Tahan Asam (BTA) pada Pasien Penyakit Tuberculosis Paru di RSUD Langsa. Biologica Samudra, 1(2): 6-15.
16. Pratiwi, M. 2019. Gambaran Pengetahuan, Persepsi, dan Efek Samping Penggunaan Obat Pada Pasien Tuberkulosis Paru di Kecamatan Posigadan Tahun 2019. Universitas Negeri Gorontalo.
17. Putra, A.R. 2024. Hubungan Tingkat Keparahan Gambaran Radiografi Foto Toraks Pasien Tuberkulosis Paru dengan Jumlah Leukosit dan Trombosit di RSUD Dr. H. Abdul Moeloek Bandar Lampung, Lampung Tahun 2019-2023.
18. Rajesh, H., Sangeetha, B.S., Indhu, S., Nishanth, M. 2023. Evaluation of Hematological Profile in Pulmonary Tuberculosis. Indian Journal of Pathology and Oncology, 7(1): 39-42.
19. WHO. 2022. Global Tuberculosis Report 2022. World Health Organization. https://www.who.int/teams/global-tuberculosis-programme/tb-reports/global-tuberculosis-report-2022. Diakses tanggal 15 Juli 2023. Jam 12.40.